{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:43:25Z","timestamp":1782985405605,"version":"3.54.5"},"reference-count":26,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Zigong City Key Research Base of Philosophy and Social Sciences Sports and Health Innovation Research Center Research Project","award":["No. YDJKY24-05"],"award-info":[{"award-number":["No. YDJKY24-05"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to evaluate the associations between different treatment regimens and pregnancy outcomes, histological cure rates of chronic endometritis (CE), adverse reactions, and adverse events in patients with persistent CE and pregnancy failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 125 patients diagnosed with CE, of whom 90 were diagnosed with persistent CE. Based on the treatment regimen, the patients were divided into three groups: Group A (antibiotic therapy only), Group B (antibiotic therapy + intrauterine infusion of recombinant human granulocyte colony-stimulating factor (rhG-CSF)), and Group C (antibiotic therapy + intrauterine infusion and subcutaneous injection of rhG-CSF).The primary outcome measures were pregnancy outcomes (total pregnancy rate, clinical pregnancy rate, spontaneous abortion rate, live birth rate, and preterm birth rate), while secondary outcome measures included histological cure rate of CE, adverse reactions, and adverse events. Overall, biochemical and clinical pregnancy rates were calculated based on all patients in each group; spontaneous abortion and live birth rates were calculated based on clinical pregnancies; and the preterm birth rate was calculated based on live births.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>(1) Pregnancy outcomes: The total pregnancy rate in Group C was higher than in Group A, with no difference between Groups B and C. Biochemical pregnancy rate was higher in Group B than Group C, with no significant differences between other comparisons. Clinical pregnancy rate was higher in Group C than Group A, with no differences between other groups. Group C had the lowest spontaneous abortion rate and highest live birth rate. Preterm birth rates in Groups B and C were lower than in Group A, with no difference between B and C. Group C had the lowest spontaneous abortion rate and the highest live birth rate. Preterm birth rates in Groups B and C were lower than in Group A, with no difference between Groups B and C. (2) Factors associated with spontaneous abortion: Multivariate analysis showed Groups A and B were associated with higher odds of spontaneous abortion than Group C, and increasing age was also associated with higher odds of spontaneous abortion. (3) Histological cure rate of CE: Post-treatment, Groups B and C had higher cure rates of CE than Group A, with no difference between B and C. (4) Adverse reactions and adverse events: Subchorionic hematoma and placental adhesion were higher in Group A than Group C, no differences between other groups. No ectopic pregnancies or neonatal malformations occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>rhG-CSF combination therapy was associated with better pregnancy outcomes in persistent CE patients,including higher pregnancy, clinical pregnancy, and live birth rates, and a lower spontaneous abortion rate. Continuous use of rhG-CSF may be associated with better outcomes, but its potential clinical benefit and safety require validation through larger studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.21513","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:47:04Z","timestamp":1782982024000},"page":"e21513","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of treatment strategies on pregnancy outcomes in women with persistent chronic endometritis: a retrospective study"],"prefix":"10.7717","volume":"14","author":[{"given":"Yamin","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Reproductive Health and Infertility, Zigong Maternal and Child Health Care Hospital, Zigong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Zigong Maternal and Child Health Care Hospital, Zigong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Zigong Maternal and Child Health Care Hospital, Zigong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"6","key":"10.7717\/peerj.21513\/ref-1","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.rbmo.2019.09.008","article-title":"Use of granulocyte colony-stimulating factor in ART treatment does not increase the risk of adverse perinatal outcomes","volume":"39","author":"Cruz","year":"2019","journal-title":"Reproductive BioMedicine Online"},{"issue":"1","key":"10.7717\/peerj.21513\/ref-2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/09513590.2020.1807931","article-title":"The biochemical pregnancy loss rate remains stable up irrespective of age and differs in pattern from clinical miscarriages","volume":"37","author":"Dahan","year":"2021","journal-title":"Gynecological Endocrinology"},{"key":"10.7717\/peerj.21513\/ref-3","doi-asserted-by":"publisher","first-page":"112903","DOI":"10.1016\/j.biopha.2022.112903","article-title":"Granulocyte colony-stimulating factor in reproductive-related disease: function, regulation and therapeutic effect","volume":"150","author":"Ding","year":"2022","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"3","key":"10.7717\/peerj.21513\/ref-4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/humrep\/dey393","article-title":"Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial","volume":"34","author":"Eapen","year":"2019","journal-title":"Human Reproduction"},{"issue":"4","key":"10.7717\/peerj.21513\/ref-5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.fertnstert.2019.12.014","article-title":"Endometrial thickness is associated with incidence of small-for-gestational-age infants in fresh in vitro fertilization-intracytoplasmic sperm injection and embryo transfer cycles","volume":"113","author":"Guo","year":"2020","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.7717\/peerj.21513\/ref-6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12958-021-00810-4","article-title":"What is the impact of granulocyte colony-stimulating factor (G-CSF) in subcutaneous injection or intrauterine infusion and during both the fresh and frozen embryo transfer cycles on recurrent implantation failure: a systematic review and meta-analysis?","volume":"19","author":"Hou","year":"2021","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.7717\/peerj.21513\/ref-7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14647273.2020.1811904","article-title":"The intrauterine perfusion of granulocyte-colony stimulating factor (G-CSF) before frozen-thawed embryo transfer in patients with two or more implantation failures","volume":"31","author":"Huang","year":"2020","journal-title":"Human Fertility"},{"issue":"3","key":"10.7717\/peerj.21513\/ref-8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.fertnstert.2018.04.012","article-title":"Endometritis: new time, new concepts","volume":"110","author":"Kitaya","year":"2018","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.7717\/peerj.21513\/ref-9","doi-asserted-by":"publisher","first-page":"e13372","DOI":"10.1111\/aji.13372","article-title":"Alteration in endometrial helper T-cell subgroups in chronic endometritis","volume":"85","author":"Kitazawa","year":"2021","journal-title":"American Journal of Reproductive Immunology"},{"issue":"1","key":"10.7717\/peerj.21513\/ref-10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.fertnstert.2019.09.001","article-title":"Evaluation of peripheral and uterine immune status of chronic endometritis in patients with recurrent reproductive failure","volume":"113","author":"Li","year":"2020","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.7717\/peerj.21513\/ref-11","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3892\/mmr.2020.11017","article-title":"The role of granulocyte colony-stimulating factor in breast cancer development: a review","volume":"21","author":"Liu","year":"2020","journal-title":"Molecular Medicine Reports"},{"issue":"5","key":"10.7717\/peerj.21513\/ref-12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14647273.2022.2093137","article-title":"Recombinant human granulocyte colony stimulating factor (rhG-CSF) participates in the progression of implantation via the hsa_circ_0001550-miRNA-mRNA interaction network","volume":"26","author":"Lyu","year":"2023","journal-title":"Human Fertility"},{"issue":"3","key":"10.7717\/peerj.21513\/ref-13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.fertnstert.2021.04.036","article-title":"Redefining chronic endometritis: the importance of endometrial stromal changes","volume":"116","author":"McQueen","year":"2021","journal-title":"Fertility and Sterility"},{"key":"10.7717\/peerj.21513\/ref-14","doi-asserted-by":"publisher","first-page":"103830","DOI":"10.1016\/j.jri.2023.103830","article-title":"Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent spontaneous abortion: a systematic review and meta-analysis","volume":"156","author":"Mu","year":"2023","journal-title":"Journal of Reproductive Immunology"},{"issue":"1","key":"10.7717\/peerj.21513\/ref-15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12884-023-05831-y","article-title":"Associations between the size and duration of asymptomatic subchorionic hematoma and pregnancy outcomes in women with singleton pregnancies","volume":"23","author":"Pan","year":"2023","journal-title":"BMC Pregnancy and Childbirth"},{"key":"10.7717\/peerj.21513\/ref-16","volume-title":"Obstetrics and gynecology","author":"Peishi","year":"2021","edition":"9"},{"issue":"1","key":"10.7717\/peerj.21513\/ref-17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.fertnstert.2012.09.023","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"99","author":"Practice Committee of the American Society\u00a0for Reproductive\u00a0Medicine","year":"2013","journal-title":"Fertility and Sterility"},{"key":"10.7717\/peerj.21513\/ref-18","article-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2021"},{"key":"10.7717\/peerj.21513\/ref-19","doi-asserted-by":"publisher","first-page":"1370114","DOI":"10.3389\/fendo.2024.1370114","article-title":"The value of G-CSF in women experienced at least one implantation failure: a systematic review and meta-analysis","volume":"15","author":"Su","year":"2024","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.7717\/peerj.21513\/ref-20","first-page":"205","article-title":"Impact of recombinant human granulocyte colony-stimulating factor combined with aspirin on clinical pregnancy outcomes and endometrial receptivity in patients with recurrent abortion: a retrospective study","volume":"30","author":"Sun","year":"2024","journal-title":"Alternative Therapies in Health and Medicine"},{"key":"10.7717\/peerj.21513\/ref-21","doi-asserted-by":"publisher","first-page":"986893","DOI":"10.3389\/fimmu.2022.986893","article-title":"Anticardiolipin and\/or anti-\u03b22-glycoprotein-I antibodies are associated with adverse IVF outcomes","volume":"13","author":"Wu","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.7717\/peerj.21513\/ref-22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/09513590.2022.2036716","article-title":"The therapeutic effect of granulocyte colony stimulating factor (G-CSF) on potential biochemical pregnancy in patients with unexplained repeated transplantation failure (RIF): a case series and literature review","volume":"38","author":"Wu","year":"2022","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.7717\/peerj.21513\/ref-23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12958-024-01221-x","article-title":"Uterine infusion strategies for infertile patients with recurrent implantation failure: a systematic review and network meta-analysis","volume":"22","author":"Xie","year":"2024","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"2","key":"10.7717\/peerj.21513\/ref-24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/mi.2024.134","article-title":"Subchorionic hematoma: research status and pathogenesis (Review)","volume":"4","author":"Xu","year":"2024","journal-title":"Medicine International"},{"key":"10.7717\/peerj.21513\/ref-25","doi-asserted-by":"publisher","first-page":"1616217","DOI":"10.3389\/fimmu.2025.1616217","article-title":"Inflammatory mechanisms and therapeutic advances in chronic endometritis","volume":"16","author":"Yan","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10.7717\/peerj.21513\/ref-26","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/diagnostics12112711","article-title":"Challenges in clinical diagnosis and management of chronic endometritis","volume":"12","author":"Yasuo","year":"2022","journal-title":"Diagnostics"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/21513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21513.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21513.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:47:08Z","timestamp":1782982028000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/21513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":26,"alternative-id":["10.7717\/peerj.21513"],"URL":"https:\/\/doi.org\/10.7717\/peerj.21513","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"e21513"}}